Mounjaro was developed by the pharmaceutical company Eli Lilly and first approved for medical use in 2022. It’s based on years of research into dual hormone therapies that target both GIP and GLP-1 pathways. Its effectiveness has since been demonstrated in large international trials, helping establish it as a new generation of treatment for type 2 diabetes and weight management. How Mounjaro began The story of Mounjaro started in the early 2010s, when researchers explored way

Yes. You can change to a new weekly day as long as at least 3 full days have passed since your last injection. Once you switch, keep...

Any time of day works — morning or evening — because the weekly dose is designed to be flexible. Pick a time you can stick to, keep it...

The vast majority of patients on Mounjaro currently pay for it privately but some patients can get it on the NHS...

Yes, Wegovy and metformin are often used together in people with type 2 diabetes, and no special dose adjustment is typically required....

In major STEP trials, Wegovy led to about 15% weight loss over 68 weeks. Contrave (called Mysimba in the UK) generally achieves around...

Wegovy contains semaglutide at a higher dose and is licensed for weight management, while Trulicity (dulaglutide) is prescribed for type...

Standard UK instructions start at 0.25 mg once weekly and step up gradually to improve comfort and reduce tummy side effects. Starting at...

Recommended sites are the abdomen, thigh, or upper arm. Rotate sites each week to reduce local irritation, and avoid areas that are...

Many people on Wegovy report fewer food cravings and better control over eating, which can reduce stress around meals. Other drugs like...

Clinical trials included adults up to their mid-70s, and weight loss benefits were seen across age groups. There’s limited evidence...

Both contain semaglutide and improve blood sugar by enhancing insulin release and reducing glucagon. Ozempic is specifically licensed for...

Yes — trials show Wegovy users lose more weight earlier than with Saxenda, thanks to its stronger appetite effect and weekly dosing. That...

In many cases, Wegovy can be used as the main weight loss medicine, especially when diet and exercise alone haven’t worked. However,...

Wegovy mimics the hormone GLP-1, acting on the brain to reduce appetite and slow digestion. Contrave (naltrexone/bupropion) affects brain...

Yes, NICE guidance states that Wegovy can be offered to adults with a BMI over 35 and at least one weight-related condition, or sometimes...

Trials such as STEP-1 and SELECT showed Wegovy not only reduced weight but also improved blood pressure, cholesterol, and markers of...

Neither Wegovy nor Saxenda requires strict dietary rules. Both are prescribed alongside a reduced-calorie diet and increased physical...

In STEP trials, people using Wegovy started to see weight changes within the first 4–8 weeks, with maximum effects building over about a...

Wegovy is taken once weekly via an injection pen, with doses stepped up over 16 weeks. Saxenda requires a daily injection, Mounjaro is a...